Preface

Therapeutic agents have an impressive history in drug discovery and development which led to the identification of numerous phenomenal lead drug candidates. The current therapeutic regimens are allied with several inverse biological effects. Therefore, there is an urgent need for innovative and technological strategies to help in medical diagnosis and management. With the advancement of new technologies in medicinal chemistry, several highly specific, biocompatible, and non-toxic therapeutic agents are discovered and successfully applied for diverse clinical applications. Nanotechnology has perceived historic progress in the last few decades and recently proved its efficacy in every field of science and technology. Nanotechnology-based pharmaceuticals offered multifaceted and alternative methodologies to an overwhelmed conventional limitation of clinical therapies. Expertise in designing and developing nanoformulation helped in targeted drug delivery. Recently, the use of innovative therapeutic agents, particularly in nanomedicine, has accounted for a significant portion of the global pharmaceutical market and is predicted to continue to grow rapidly in the near future.

Dr. Shahid has worked on a variety of scientific platforms over the years. He has authored multiple research publications and is well-known for his scientific knowledge. In 2019, he envisioned creating a comprehensive book on nanotherapeutics in the biological sector, which had previously been spread across the literature. Dr. Saad Salman and Dr. Youssef O. Al-Ghamdi, the co-editors, later joined hands in this scientific voyage. This book is the result of over ten years of research and the diverse contributions of more than 50 fertile brains. Many well-known scientists from various countries, including the United States, the United Kingdom, Italy, Pakistan, Malaysia, India, and Bangladesh, contributed numerous book chapters to the premises of the book titled “Nanotherapeutic strategies and new pharmaceuticals” in this book series, which resulted in volume I and II. For instance, COVID-19: an outbreak, application of nanotherapeutics agents in disease control, wound healing, surgery, stem cell, central nervous, haematology, cancer therapy, Gene therapy/editing and many more. Volume-I contains 11 chapters and each chapter has a minimum of 6,000 words. This indicates that each chapter has been meticulously detailed and structured.

Furthermore, each chapter is written by specialists in respective fields, and it was made mandatory to keep it as easy as possible to make it accessible to both beginners and experts. As a result, this book is one of the best for a wide range of readers. Furthermore, this book is structured to address a wide range of topics relevant to chemists, biologists, pharmacists, and material scientists.

We are very thankful to all the authors who spare time from their busy schedules and contributed their ideas and knowledge to this book. In addition, we also pay our sincerest gratitude to the team of Bentham Science, who made great efforts to make this book series possible.